Methods of reducing the astringency of stannous in dentifrice compositions
AssigneeThe Procter & Gamble Company
InventorWilliam Michael Glandorf
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Procter & Gamble Company
InventorWilliam Michael Glandorf
Estimating the term…
Disclosed are methods for reducing the astringency of dentifrice composition containing stannous comprising administering to the subject a dentifrice composition comprising stannous. The dentifrice composition comprises stannous ions, poloxamer, and aqueous carriers. The efficacy of this dentifrice composition containing stannous will not be reduced by the poloxamer. The dentifrice composition may also contain a polyphosphate as long as the water content is limited and the stannous ion is not provided from stannous fluoride. The polyphosphate will also not reduce the efficacy of the stannous. Alternatively, the dentifrice composition may be a dual phase composition. The first dentifrice composition will contain a polyphosphate having an average chain length of about 4 or more and have a limited water content while the second dentifrice composition will contain stannous ions. In the dual phase composition, the poloxamer will be present in the first or second dentifrice compositions or both compositions. Neither the polyphosphate or the poloxamer will reduce the efficacy of the stannous.
A method of reducing astringency of a dentifrice composition containing stannous for administration to a subject, comprising including in said dentifrice composition:
A method of reducing astringency of a dual-phase dentifrice composition containing stannous for administration to a subject, comprising including in said dentifrice composition contained in physically separated compartments of a dentifrice dispenser:
Dependencies are inferred from the claim text.